ATE397065T1 - Regulatorische konstrukte, die das intron 3 des prostat-spezifischen membranatigen-gens enthalten - Google Patents

Regulatorische konstrukte, die das intron 3 des prostat-spezifischen membranatigen-gens enthalten

Info

Publication number
ATE397065T1
ATE397065T1 AT00906080T AT00906080T ATE397065T1 AT E397065 T1 ATE397065 T1 AT E397065T1 AT 00906080 T AT00906080 T AT 00906080T AT 00906080 T AT00906080 T AT 00906080T AT E397065 T1 ATE397065 T1 AT E397065T1
Authority
AT
Austria
Prior art keywords
membranate
igen
intron
prostate
gene
Prior art date
Application number
AT00906080T
Other languages
English (en)
Inventor
Peter Molloy
Fujiko Watt
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP8956A external-priority patent/AUPP895699A0/en
Priority claimed from AUPQ5268A external-priority patent/AUPQ526800A0/en
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Application granted granted Critical
Publication of ATE397065T1 publication Critical patent/ATE397065T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00906080T 1999-03-01 2000-03-01 Regulatorische konstrukte, die das intron 3 des prostat-spezifischen membranatigen-gens enthalten ATE397065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP8956A AUPP895699A0 (en) 1999-03-01 1999-03-01 Regulatory element
AUPQ5268A AUPQ526800A0 (en) 2000-01-25 2000-01-25 Regulatory element ii

Publications (1)

Publication Number Publication Date
ATE397065T1 true ATE397065T1 (de) 2008-06-15

Family

ID=25646003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906080T ATE397065T1 (de) 1999-03-01 2000-03-01 Regulatorische konstrukte, die das intron 3 des prostat-spezifischen membranatigen-gens enthalten

Country Status (11)

Country Link
US (2) US7074400B1 (de)
EP (1) EP1157105B8 (de)
JP (1) JP4528446B2 (de)
AT (1) ATE397065T1 (de)
AU (1) AU773906B2 (de)
CA (1) CA2364492C (de)
DE (1) DE60039032D1 (de)
ES (1) ES2307495T3 (de)
IL (2) IL145142A0 (de)
NZ (1) NZ513731A (de)
WO (1) WO2000052156A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU773906B2 (en) * 1999-03-01 2004-06-10 Commonwealth Scientific And Industrial Research Organisation Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
US7252824B2 (en) * 2001-03-07 2007-08-07 Mannkind Corporation Anti-neovasculature preparations for cancer
JP2003079365A (ja) * 2001-09-07 2003-03-18 Kanegafuchi Chem Ind Co Ltd 環境有害化学物質の高感度検出法
EP3184539A3 (de) 2001-10-23 2017-09-13 PSMA Development Company L.L.C. Psma antikörper
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
CA2469623C (en) 2001-12-12 2012-05-29 F H Faulding & Co Limited Composition for the preservation of viruses
AUPS145602A0 (en) * 2002-03-28 2002-05-09 Commonwealth Scientific And Industrial Research Organisation Composition and method for killing tumours
US20030235874A1 (en) * 2002-05-08 2003-12-25 Chinghai Kao Prostate-specific chimeric enhancers and methods of use thereof
EP1592454A1 (de) * 2003-01-22 2005-11-09 Magnus Essand Tarp-promotor und verwendung dafür

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0668777T3 (da) * 1992-11-05 2007-02-19 Sloan Kettering Inst Cancer Prostataspecifikt membran-antigen
AUPM710194A0 (en) * 1994-07-26 1994-08-18 Commonwealth Scientific And Industrial Research Organisation Virus vector
ATE317435T1 (de) 1995-02-24 2006-02-15 Sloan Kettering Inst Cancer Prostataspezifisches membranes antigen und seine anwendungen
AUPN477695A0 (en) * 1995-08-14 1995-09-07 Commonwealth Scientific And Industrial Research Organisation Gene therapy
AUPO492397A0 (en) 1997-02-03 1997-02-27 Commonwealth Scientific And Industrial Research Organisation Prostate specific promoters
AU773906B2 (en) * 1999-03-01 2004-06-10 Commonwealth Scientific And Industrial Research Organisation Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene

Also Published As

Publication number Publication date
DE60039032D1 (de) 2008-07-10
IL145142A0 (en) 2002-06-30
AU2786800A (en) 2000-09-21
IL145142A (en) 2010-12-30
US20060183229A1 (en) 2006-08-17
CA2364492A1 (en) 2000-09-08
NZ513731A (en) 2002-10-25
JP2002537807A (ja) 2002-11-12
AU773906B2 (en) 2004-06-10
EP1157105A1 (de) 2001-11-28
JP4528446B2 (ja) 2010-08-18
US7871819B2 (en) 2011-01-18
EP1157105B1 (de) 2008-05-28
ES2307495T3 (es) 2008-12-01
EP1157105A4 (de) 2003-01-15
WO2000052156A1 (en) 2000-09-08
CA2364492C (en) 2014-08-19
US7074400B1 (en) 2006-07-11
EP1157105B8 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
HU9601073D0 (en) Rekombinant adenoviral vector and methods of use
MY120693A (en) Human bikunin
NO20042191L (no) Simian-adenovirusnukleinsyre og aminosyresekvenser, vektorer inneholdende disse, og fremgangsmater for deres anvendelse
DE69914309D1 (de) Tadg15: eine extrazelluläre serinprotease überexprimiert in brust- und eierstock-karzinomen
ATE277081T1 (de) Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
ATE397065T1 (de) Regulatorische konstrukte, die das intron 3 des prostat-spezifischen membranatigen-gens enthalten
IL199126A (en) Promoters for expression in modified vaccinia virus ankara (mva) and vectors comprising said promoters.
GR852940B (de)
EP1572889A4 (de) Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahren
GB0027088D0 (en) DNA expression vectors
GB2368064B (en) DNA Element and Associated Protein
DE69838681D1 (de) Escherichia coli hochexpressionsvektor
PL313445A1 (en) Grb3-3 gene, variants thereof and their use
NZ334839A (en) Polynucleotide molecules encoding neospora proteins and uses thereof
IL174645A0 (en) MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
ATE399864T1 (de) Dna kodierend für das schaf-adenovirus (oav287) und ihre verwendung als viralen vektor
ATE262034T1 (de) Xylanasen, für diese kodierende gene und anwendungen derselben
HUP9902298A2 (hu) Tirozin-hidroxiláz génből származó expressziós rendszer
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
ATE506444T1 (de) Modifizierter cea/b7-vektor
EP1221485A3 (de) Für Neosporaproteine kodierende Polynukleinsäuren
DK0663955T3 (da) Nucleinsyre, som koder for en alfa-acetolactat-decarboxylase, og anvendelser deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1157105

Country of ref document: EP